New York Life IM Files Schedule 13G/A Showing No Holdings in Invesco ETF
Rhea-AI Filing Summary
New York Life Investment Management LLC filed an amendment to Schedule 13G reporting its position in the Invesco S&P SmallCap Quality ETF. The filing shows the reporting person beneficially owns 0 shares of the class, representing 0% of the outstanding shares, with no sole or shared voting or dispositive power. The filing indicates the ownership is held in the ordinary course of business and not for the purpose of influencing control of the issuer. The statement is signed by Paul Vengrow, Corporate Vice President, and reflects information specific to the CUSIP 46138G300.
Positive
- None.
Negative
- None.
Insights
TL;DR: Filing shows no beneficial ownership by the reporting adviser, indicating no active stake in the ETF.
The Schedule 13G amendment documents that New York Life Investment Management LLC holds zero shares and zero voting or dispositive power in the Invesco S&P SmallCap Quality ETF (CUSIP 46138G300). For investors and compliance officers, this is a routine disclosure that confirms the filer is not a holder and is not seeking control. The certification language reiterates ordinary-course holding criteria. There are no transactions, holdings, or material changes disclosed within this filing.
TL;DR: The amendment is a compliance-driven filing with neutral governance impact.
This Schedule 13G/A provides a clear, formal record that the reporting entity does not possess voting or dispositive influence over the issuer. From a governance perspective, the filing imposes no change to shareholder composition or control dynamics. It serves primarily as regulatory transparency rather than signaling strategic intent or corporate action.